Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating immunotherapy-related toxicity using a GM-CSF antagonist

Methods of treating immunotherapy-related toxicity using a GM-CSF antagonist

US Patent 10870703 · Granted Dec 22, 2020

Estimated economic value: $39,666,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EphA3 directed CAR-T cells for treatment of tumors2024
EphA3 directed CAR-T cells for treatment of tumors2024
A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method 2023
Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab2023
Method of increasing the efficacy of CAR-T immunotherapy using lenzilumab2023
Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF2021
Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF2021
Method of reducing tumor relapse rate in immunotherapy by administration of lenz2021
Method of reducing tumor relapse rate in immunotherapy by administration of lenz2021
Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy2021
Method of reducing the level of non-GM-CSF cytokines/chemokines in immunotherapy2021
A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method 2020